Viltepso fda approval date?

When was Viltepso approved by the FDA?

Viltepso (viltolarsen) received FDA approval on April 10, 2020. [1]

What is Viltepso, and what condition does it treat?

Viltepso is an antisense oligonucleotide indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation amenable to exon 53 skipping. [1]

Where can I verify the approval date?

You can confirm the FDA approval date via DrugPatentWatch.com. [1]

Sources

[1] https://drugpatentwatch.com/2019/05/15/viltepso-fda-approval-date/